1 hr ago
Obesity Drugs Advance as Medicine Debates What Obesity Means
Doctors now have medicines that can help people with obesity lose a lot of weight.
These medicines are called GLP-1 receptor agonists.
They can reduce a person’s weight by a fifth or more.
This is more effective than many older approaches involving diets and advice.
One of these medicines is called Wegovy.
Novo Nordisk makes Wegovy.
Britain is the second large market, after America, to offer Wegovy as a tablet.
The medicine can also be taken by injection, but doctors still do not fully agree on what obesity means.
GLP-1 receptor agonists can reduce patients’ body weight by a fifth or more.
The drugs achieve weight loss that decades of diets and exhortation did not.
Britain has become the second large market to offer Novo Nordisk’s Wegovy.
Wegovy is now available in tablet form as an alternative to injections.
The article highlights continuing disagreement within medicine over how obesity should be defined.
- Who
- People with obesity, doctors, Novo Nordisk, and medicine researchers are involved.
- What
- A class of GLP-1 drugs can produce major weight loss, while medicine continues to debate the definition of obesity.
- Where
- Britain became the second large market after America to make tablet-form Wegovy available.
- When
- This week, according to the article.
- Why
- The tablet provides an alternative to injecting Wegovy, while the broader medical debate concerns how obesity should be defined.
Key facts
- Drug class
- GLP-1 receptor agonists
- Reported weight loss
- A fifth or more of a patient’s body weight
- Medicine highlighted
- Novo Nordisk’s Wegovy
- New formulation
- Tablet
- Alternative formulation
- Injection
- Market milestone
- Britain became the second large market, after America, to offer tablet-form Wegovy
Sources
Related news
Doctors Warn Against Treating Ozempic as a Weight-Loss Shortcut
Expert Questions Whether GLP-1 Drugs Are Creating New Diet Culture
Mounjaro Becomes India’s Top-Selling Drug Amid GLP-1 Shift
Kunal Kapoor Says Weight-Loss Drugs Need Responsible Medical Guidance
Top Doctor Says GLP-1 Drugs May Transform PMOS Treatment
Novo Nordisk Eyes Hair-Loss Treatments Beyond Obesity Drugs
Rubio Says Foreign Actor May Link To UK Airbase Incident
Russia Threatens Nuclear Response Over Hypothetical Kaliningrad War Game
Lawrence Dallaglio Auctions 2003 World Cup Medal Amid Bankruptcy
FBI Lists Goldy Brar, Spotlighting Global Bishnoi Network
